# The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC

> **NCT00071266** · PHASE3 · COMPLETED · sponsor: **Kos Pharmaceuticals** · enrollment: 870 (—)

## Conditions studied

- Intermittent Claudication
- Peripheral Vascular Disease

## Interventions

- **DRUG:** Niacin Extended Release and Lovastatin Tablets

## Key facts

- **NCT ID:** NCT00071266
- **Lead sponsor:** Kos Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 870 (—)
- **Last updated:** 2006-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00071266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00071266, "The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00071266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*